glp-1 manufacturers in india emerging as a key backend and manufacturing hub for obesity drugs. Pharma players positioned across brands, APIs, peptides & CDMO value chain. Long-term opportunity driven by global obesity and diabetes Lilly to Invest $3B to
Pay in 4 interest-free payments of $5.37 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16















:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
:max_bytes(150000):strip_icc()/VWH-GettyImages-2059065209-7ab09bdd0be8409493ace4364fccf792.jpg)










